Prothena Plc Company Insiders
PRTA Stock | USD 14.53 0.75 5.44% |
Prothena Plc's insiders are aggressively selling. The analysis of the overall insider sentiment regarding Prothena plc suggests that vertually all insiders are panicking. Prothena Plc employs about 173 people. The company is managed by 14 executives with a total tenure of roughly 23 years, averaging almost 1.0 years of service per executive, having 12.36 employees per reported executive.
Wagner Zago Executive Chief Scientific Officer |
Carol Karp Executive Chief Regulatory Officer |
Prothena Plc's Insider Buying Vs Selling
0
Selling | Buying |
Latest Trades
2024-01-24 | Karin L. Walker | Disposed 5000 @ 34 | View | ||
2023-12-20 | Karin L. Walker | Disposed 5000 @ 37.19 | View |
Monitoring Prothena Plc's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Prothena |
Prothena Plc's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Prothena Plc's future performance. Based on our forecasts, it is anticipated that Prothena will maintain a workforce of about 170 employees by January 2025.Prothena Plc Management Team Effectiveness
The company has return on total asset (ROA) of (0.1566) % which means that it has lost $0.1566 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.229) %, meaning that it created substantial loss on money invested by shareholders. Prothena Plc's management efficiency ratios could be used to measure how well Prothena Plc manages its routine affairs as well as how well it operates its assets and liabilities. As of December 4, 2024, Return On Tangible Assets is expected to decline to -0.22. The current year's Return On Capital Employed is expected to grow to -0.28. At present, Prothena Plc's Other Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 16.1 M, whereas Total Assets are forecasted to decline to about 414.8 M.As of December 4, 2024, Common Stock Shares Outstanding is expected to decline to about 35.1 M. In addition to that, Net Loss is expected to decline to about (110.5 M)
Prothena Plc Workforce Comparison
Prothena plc is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 2,996. Prothena Plc holds roughly 173 in number of employees claiming about 6% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.99) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (68.57) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $68.57. Prothena Plc Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Prothena Plc insiders, such as employees or executives, is commonly permitted as long as it does not rely on Prothena Plc's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Prothena Plc insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-03-01 | 5.5 | 11 | 2 | 1,093,000 | 10,000 |
2023-12-01 | 0.3333 | 5 | 15 | 24,000 | 48,000 |
2023-09-01 | 0.3333 | 18 | 54 | 76,000 | 152,000 |
2023-06-01 | 0.4407 | 26 | 59 | 376,333 | 482,666 |
2023-03-01 | 0.5294 | 18 | 34 | 588,834 | 215,668 |
2022-12-01 | 0.2564 | 20 | 78 | 239,500 | 454,280 |
2022-09-01 | 0.3889 | 14 | 36 | 194,662 | 399,246 |
2022-06-01 | 1.5 | 15 | 10 | 1,252,736 | 1,092,736 |
2022-03-01 | 4.0 | 12 | 3 | 1,165,500 | 5,000 |
2021-12-01 | 0.2667 | 8 | 30 | 72,519 | 145,038 |
2021-09-01 | 0.3824 | 13 | 34 | 146,676 | 99,646 |
2021-06-01 | 1.5 | 15 | 10 | 774,250 | 245,000 |
2021-03-01 | 1.4146 | 58 | 41 | 3,310,222 | 1,434,200 |
2020-09-01 | 1.0 | 1 | 1 | 10,000 | 10,000 |
2018-12-01 | 0.5 | 1 | 2 | 35,000 | 130,000 |
2017-12-01 | 0.3333 | 1 | 3 | 3,500 | 7,000 |
2017-09-01 | 0.4348 | 10 | 23 | 54,600 | 109,200 |
2017-06-01 | 0.8462 | 11 | 13 | 200,500 | 123,000 |
2017-03-01 | 0.8235 | 14 | 17 | 374,709 | 97,418 |
2016-12-01 | 0.5294 | 9 | 17 | 172,292 | 84,584 |
2016-09-01 | 0.4615 | 6 | 13 | 79,500 | 59,000 |
2016-06-01 | 1.0 | 12 | 12 | 104,000 | 27,820 |
2016-03-01 | 1.1 | 11 | 10 | 592,125 | 14,250 |
2015-12-01 | 0.3143 | 11 | 35 | 182,916 | 359,166 |
2015-09-01 | 0.3235 | 11 | 34 | 109,916 | 209,833 |
2015-06-01 | 1.1429 | 8 | 7 | 120,125 | 30,250 |
2015-03-01 | 1.6667 | 10 | 6 | 443,625 | 37,250 |
2014-12-01 | 0.5 | 3 | 6 | 7,500 | 15,000 |
2014-09-01 | 1.0 | 2 | 2 | 4,500 | 5,000 |
2014-06-01 | 4.0 | 8 | 2 | 147,356 | 16,000 |
2014-03-01 | 7.0 | 7 | 1 | 402,000 | 3,182,253 |
2013-09-01 | 1.0 | 1 | 1 | 50,000 | 0.00 |
Prothena Plc Notable Stakeholders
A Prothena Plc stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Prothena Plc often face trade-offs trying to please all of them. Prothena Plc's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Prothena Plc's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Hideki MD | Chief Officer | Profile | |
CPA CPA | Chief Controller | Profile | |
Jennifer Zibuda | Director Communication | Profile | |
Brandon Smith | Chief Officer | Profile | |
Wagner Zago | Chief Scientific Officer | Profile | |
Carol Karp | Chief Regulatory Officer | Profile | |
David Ford | Chief Officer | Profile | |
Chad Swanson | Chief Officer | Profile | |
Yvonne Tchrakian | Company Secretary | Profile | |
Michael Malecek | Chief Secretary | Profile | |
Mark CFA | Vice Relations | Profile | |
Karin CPA | Chief Controller | Profile | |
Tran MBA | CFO Officer | Profile | |
Gene Kinney | Chief Scientific Officer and Head of RandD | Profile |
About Prothena Plc Management Performance
The success or failure of an entity such as Prothena plc often depends on how effective the management is. Prothena Plc management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Prothena management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Prothena management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.21) | (0.22) | |
Return On Capital Employed | (0.30) | (0.28) | |
Return On Assets | (0.21) | (0.22) | |
Return On Equity | (0.26) | (0.25) |
Please note, the presentation of Prothena Plc's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Prothena Plc's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Prothena Plc's management manipulating its earnings.
Prothena Plc Workforce Analysis
Traditionally, organizations such as Prothena Plc use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Prothena Plc within its industry.Prothena Plc Manpower Efficiency
Return on Prothena Plc Manpower
Revenue Per Employee | 528.2K | |
Revenue Per Executive | 6.5M | |
Net Loss Per Employee | 849.9K | |
Net Loss Per Executive | 10.5M | |
Working Capital Per Employee | 3.4M | |
Working Capital Per Executive | 41.6M |
Complementary Tools for Prothena Stock analysis
When running Prothena Plc's price analysis, check to measure Prothena Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Prothena Plc is operating at the current time. Most of Prothena Plc's value examination focuses on studying past and present price action to predict the probability of Prothena Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Prothena Plc's price. Additionally, you may evaluate how the addition of Prothena Plc to your portfolios can decrease your overall portfolio volatility.
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |